Faculty Profile
David Glahn, PhD
Director, Tommy Fuss Center for Neuropsychiatric Disease Research
Director, Early Psychosis Investigation Center (EPICenter)
Director, Neuropsychiatric Genetics Program
Professor of Psychology, Department of Psychiatry
Genetics effect on psychotic and affective disorders.
The overarching goal of Dr. David Glahn’s research is to discover genes and environmental mechanisms that predispose affective and psychotic disorders in children and adults. To achieve this goal, he develops and applies neuroanatomic, functional neuroimaging, and neurocognitive endophenotypes in large-scale family-based studies. Dr. Glahn’s research program involves four broad scientific aims: 1) To identify and characterize genes and environmental factors influencing risk for psychotic and affective disorders and their endophenotypes; 2) To specify genetic and environmental influences on normal variation of brain structure/function and cognitive ability; 3) To isolate genetic and environmental factors involved in human cognitive and brain development, particularly during adolescence; and 4) To develop novel endophenotypes for psychotic and affective disorders and markers of cognitive and brain development.
Affiliations
Harvard Medical School
Publications